Form 8-K - Current report:
SEC Accession No. 0001493152-24-039417
Filing Date
2024-10-03
Accepted
2024-10-03 17:30:32
Documents
13
Period of Report
2024-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38388
  Complete submission text file 0001493152-24-039417.txt   214966

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gnlx-20240923.xsd EX-101.SCH 3012
3 XBRL LABEL FILE gnlx-20240923_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gnlx-20240923_pre.xml EX-101.PRE 24163
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3856
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41599 | Film No.: 241352753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)